The historical rank and industry rank for Abbott India's OCF Margin % or its related term are showing as below:
BOM:500488'
s OCF Margin % Range Over the Past 10 Years
Min: 4.63 Med: 16.25 Max: 20.74
Current: 19.04
During the past 13 years, the highest OCF Margin % of Abbott India was 20.74%. The lowest was 4.63%. And the median was 16.25%.
BOM:500488's OCF Margin % is ranked better than 75.91% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs BOM:500488: 19.04
Abbott India OCF Margin % Related Terms
Abbott India OCF Margin % Historical Data
* Premium members only.
The historical data trend for Abbott India's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Abbott India's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott India OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Abbott India's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Abbott India's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott India (BOM:500488) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Abbott India and its competitors. Over the past decade, Abbott India's OCF Margin % has ranged from 4.63 to 20.74. According to the industry distribution chart, Abbott India ranks #231 out of 959 companies in the Drug Manufacturers industry, placing it in the top 24.1%.
Is Abbott India's OCF Margin % too high?
Abbott India's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 4.63 to a high of 20.74. Based on the distribution chart, Abbott India ranks #231 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott India has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott India's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Abbott India ranks #231 out of 959 companies for OCF Margin %. This places Abbott India in the top 24% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Historically, Abbott India's own OCF Margin % has ranged from 4.63 to 20.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Abbott India and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott India's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott India stock overvalued right now?
Based on GuruFocus' analysis, Abbott India (BOM:500488) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹32,313.61, compared to a current price of ₹25,566.95 — trading 20.9% below its estimated fair value. The current OCF Margin % is 0.00%. Abbott India's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Abbott India (BOM:500488), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott India (BOM:500488) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott India stock appears to be undervalued.
The current stock price of ₹25,566.95 is trading 20.9% below its estimated GF Value™ of ₹32,313.61.
GuruFocus considers Abbott India to be Modestly Undervalued.
Key valuation signals for BOM:500488:
OCF Margin %: 0.00%
GF Value™: ₹32,313.61 vs. price of ₹25,566.95 (20.9% below fair value)
No single metric tells the full story. See the BOM:500488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
87GF Score
Get the complete analysis for BOM:500488
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500488 has been successfully added to your 
